Biofrontera Inc.

Nasdaq:BFRINasdaq:BFRIW

Pharmaceutical Preparations·WOBURN, MA

CEO

Luebbert Hermann

CFO

Leffler Eugene Frederick

Financials

17 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

18 shown

Filed	Period
1/13/26	Q4 FY2026	→
11/13/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
3/21/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
↓

News (8-K)

62 shown

Filed	Type	Description
3/9/26	Reg FD	Regulation FD Disclosure	→
2/26/26	Other	Other Events	→
2/9/26	Reg FD	Regulation FD Disclosure	→
1/7/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
11/10/25	Other	Other Events	→
11/7/25	Acquisition	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/5/25	S-1	S-1	→
8/13/25	S-1/A	S-1/A	→
7/16/25	S-1	S-1	→
1/17/25	S-1	S-1	→
11/13/24	S-8	S-8	→
5/3/24	S-1	S-1	→
↓

Filing History(349 filings)

TypeDateAccessionPeriodSize

8-K

Mar 9, 2026

0001493152-26-0093218-K

Mar 9, 2026

273.9 KB

Mar 6, 2026

0001493152-26-0092594

Mar 4, 2026

5.3 KB

Mar 6, 2026

0001493152-26-0092574

Mar 4, 2026

12.8 KB

Mar 6, 2026

0001493152-26-0092554

Mar 4, 2026

12.8 KB

Mar 6, 2026

0001493152-26-0092534

Mar 4, 2026

5.3 KB

Mar 6, 2026

0001493152-26-0092514

Mar 4, 2026

5.3 KB

Mar 6, 2026

0001493152-26-0092494

Mar 4, 2026

8.2 KB

Mar 6, 2026

0001493152-26-0092474

Mar 4, 2026

5.3 KB

8-K

Feb 26, 2026

0001493152-26-0081368-K

Feb 23, 2026

270.5 KB

SCHEDULE 13G/A

Feb 11, 2026

0001622627-26-000005

—

15.9 KB

8-K

Feb 9, 2026

0001493152-26-0057178-K

Feb 9, 2026

282.9 KB

SCHEDULE 13G/A

Jan 28, 2026

0001493152-26-003976

—

9.4 KB

8-K

Jan 13, 2026

0001493152-26-0019598-K

Jan 13, 2026

287.3 KB

8-K

Jan 7, 2026

0001493152-26-0008238-K

Dec 31, 2025

261.2 KB

EFFECT

Dec 19, 2025

9999999995-25-003865

—

1.7 KB

S-1

Dec 5, 2025

0001493152-25-026443S-1

—

831.6 KB

8-K

Nov 13, 2025

0001493152-25-0221338-K

Nov 13, 2025

380.7 KB

10-Q

Nov 12, 2025

0001493152-25-02194510-Q

Sep 30, 2025

5.6 MB

SCHEDULE 13G/A

Nov 12, 2025

0001622627-25-000036

—

15.8 KB

8-K

Nov 10, 2025

0001493152-25-0215258-K

Nov 4, 2025

257.6 KB

8-K

Nov 7, 2025

0001493152-25-0211898-K

Nov 6, 2025

728.6 KB

8-K

Oct 24, 2025

0001493152-25-0193708-K

Oct 20, 2025

868.4 KB

8-K

Oct 23, 2025

0001493152-25-0190068-K

Oct 23, 2025

289.5 KB

Sep 30, 2025

0001213900-25-093449OWNERSHIP DOCUMENT

Sep 16, 2025

3.5 KB

Sep 30, 2025

0001213900-25-093444OWNERSHIP DOCUMENT

Sep 16, 2025

7.4 KB

25 filings shown

Filed	Form	Description
8/5/25	DEF 14A	DEF 14A	→
7/25/25	PRE 14A	PRE 14A	→
6/3/25	DEFR14A	DEFR14A	→
4/30/25	DEF 14A	DEF 14A	→
4/18/25	PRE 14A	PRE 14A	→
4/30/24	DEFR14A	DEFR14A	→
↓

Biofrontera Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(349 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	4	4	→
3/6/26	4	4	→
3/6/26	4	4	→
3/6/26	4	4	→
3/6/26	4	4	→
3/6/26	4	4	→
↓

Filed	Form	Description
2/11/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/28/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/19/25	EFFECT	EFFECT	→
11/12/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
9/19/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/19/25	EFFECT	EFFECT	→
↓